Central nervous system aspergillosis in allogeneic stem cell transplant recipients

Bone Marrow Transplantation

Volumn 31, Issue 3, 2003, Pages 191-196

  Jantunen, E ^a,b   Volin, L ^a   Salonen, O ^a   Piilonen, A ^a   Parkkali, T ^a   Anttila, V J ^a   Paetau, A ^a   Ruutu, T ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Allogeneic stem cell transplantation; Aspergillosis; Central nervous system; Radiology

Indexed keywords

AMPHOTERICIN B; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CONVULSION; DISEASE COURSE; FEMALE; GRAFT VERSUS HOST REACTION; HEMIPARESIS; HUMAN; INCIDENCE; LUNG ASPERGILLOSIS; MALE; MENTAL DISEASE; MORTALITY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; SURVIVAL TIME; SYMPTOMATOLOGY; TREATMENT PLANNING;

ADOLESCENT; ADULT; ASPERGILLOSIS; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; FEMALE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037293505     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703812     Document Type: Article

References (37)

1. McWhinney PHM, Kibbler CC, Hamon MD et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: a 13 years' experience. Clin Infect Dis 1993; 17: 397-404.
2. Saugier-Veber P, Devergie A, Sulahian A et al. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study. Bone Marrow Transplant 1993; 12: 121-124.
3. Jantunen E, Ruutu P, Niskanen L et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997; 17: 801-808.
4. Wald A, Leisenring W, van Burik J-A, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459-1466.
5. Ribaud P, Chastang C, Latge JP. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis 1999; 28: 322-330.
6. Jantunen E, Ruutu P, Piilonen A et al. Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000; 26: 759-762.
7. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-805.
8. Jantunen E, Piilonen A, Volin L et al. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000; 25: 867-871.
9. Beal MF, O'Carroll CP, Kleinman GM, Grossman RI. Aspergillosis of the nervous system. Neurology 1982; 32: 473-479.
10. Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: clinicopathologic analysis of 17 patients. Ann Neurol 1985; 18: 574-582.
11. Ashdown BC, Tien RD, Felsberg GJ. Aspergillosis in brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings. Am J Roentgenol 1994; 162: 155-159.
12. Pagano L, Ricci P, Montillo M et al. Localization of aspergillosis to the central nervous system among patients with acute leukemia: report of 14 cases. Clin Infect Dis 1996; 23: 628-630.
13. deLone GR, Goldstein RA, Petermann G et al. Disseminated aspergillosis involving the brain. Am J Neuroradiol 1999; 20: 1597-1604.
14. Miaux Y, Ribaud P, Williams M et al. MRI of cerebral aspergillosis in patients who have had bone marrow transplantation. Am J Neuroradiol 1995; 16: 555-562.
15. Coley SC, Jäger HR, Szydlo RM, Goldman JM. CT and MRI manifestations of central nervous system infection following bone marrow transplantation. Clin Radiol 1999; 54: 390-397.
16. Maschke M, Dietrich U, Prumbaum M et al. Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant 1999; 23: 1167-1176.
17. Dietrich U, Hettman M, Maschke M et al. Cerebral aspergillosis: comparison of radiological and neuropathologic findings in patients with bone marrow transplantation. Eur Radiol 2001; 11: 1242-1249.
18. de Medeiros BC, de Medeiros CR, Werner B et al. Central nervous system infections following bone marrow transplantation. J Hematother Stem Cell Res 2000; 9: 535-540.
19. Mohrman R, Mah V, Vinters HV. Neuropathologic findings after bone marrow transplantation: an autopsy study. Hum Pathol 1990; 21: 630-639.
20. Graus F, Saiz A, Sierra J et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukaemia: a comparative study. Neurology 1996; 46: 1004-1009.
21. Hagensee ME, Bauvens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994; 19: 402-408.
22. Kami M, Ogawa S, Kanda Y et al. Early diagnosis of central nervous system aspergillosis using polymerase chain reaction, latex agglutination test and enzyme-linked immunosorbent assay. Br J Haematol 1999; 106: 536-537.
23. Yuh WT, Nguyen HD, Gao F et al. Brain parenchymal infection in bone marrow transplant patients: CT and MRI findings. Am J Roentgenol 1994; 162: 425-430.
24. Bleggi-Torres LF, de Medeiros BC, Werner B et al. Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant 2000; 25: 301-307.
25. Denning DW. Therapeutic outcome of invasive aspergillosis. Clin Infect Dis 1996; 23: 608-615.
26. Patterson TF, Kirkpatrick WR, White M et al. for the I3 Aspergillus Study Group. Invasive aspergillosis. Disease spectrum, treatment practices and outcomes. Medicine 2000: 79: 250-260.
27. Coleman JM, Hogg GG, Rosenfeld JV, Waters KD. Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery: case report and review of the literature. Neurosurgery 1995; 36: 858-863.
28. Schwartz S, Milatovic D, Thiel E. Succesful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia. Br J Haematol 1997; 97: 663-665.
29. Baslar Z, Soysal T, Hanci M et al. Succesfully treated invasive central nervous system aspergillosis in an allogeneic stem cell transplant recipient. Bone Marrow Transplant 1998; 22: 404-405.
30. Khoury H, Adkins D, Miller G et al. Resolution of invasive central nervous system aspergillosis in a transplant recipient. Bone Marrow Transplant 1997; 20: 179-180.
31. Collete N, van der Auwera P, Pascual-Lopez A et al. Tissue distribution and bioavailability of amphotericin B in cancer patients treated with amphotericin B deoxycholate. Antimicrob Agents Chemother 1989; 33: 363-368.
32. Collete N, van der Auwera P, Meunier F et al. Tissue distribution and bioavailability of amphotericin B administered in liposomes in cancer patients. J Antimicrob Chemother 1991; 27: 535-548.
33. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994; 330: 263-272.
34. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-415.
35. Denning DW, Ribaud P Milpied N et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002; 34: 563-571.
36. Perea S, Gonzalez G, Fothergill AW et al. In vitro interaction of caspofungin acetate with voriconazole against clincal isolates of Aspergillus spp. Antimicrob Agents Chemother 2002; 46: 3039-3041.
37. Kirkpatrick WR, Perea S, Coco BJ, Patterson TF. Efficacy of caspofungin alone or in combination with voriconazole in a Guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother 2002; 46: 2564-2568.